TAMPA, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO) (CSE:DPRO) (FSE: 3U8) ("Draganfly" or the "Company"), an industry-leading developer of drone solutions, systems and technologies, today announced the closing of its previously announced registered direct offering of 1,869,159 common shares of the Company at a price of US$5.35, for gross proceeds of approximately US$10 million, before deducting placement agent discounts and offering expenses (the "Investment"). Jett Capital Advisors, LLC and Northland Capital Markets acted as joint-lead placement agents for the Investment. Draganfly intends to use the net proceeds to accelerate the development of advanced str
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Draganfly Announces Closing of US$10 Million Strategic Investment
- Faraday Future Unveils More Execution Plans for “Built In USA” Acceleration Program and Initiates the Conditional Approval Application, Will Roll out New Robot Product in Q1 2027; FF Robotics Business to Combine with AIxC (FFR) for Standalone Listing
FF held Its FF EAI "Built in USA" Upstream & Downstream Business Partner Conference Part two Upstream Partner Session & Industry Ecosystem Co-Creation Session at its headquarters and the International Conference on Intelligent Robots and Systems (IROS) in Pittsburgh, PA, featuring insights from ten partners from around the world, including MetaSense Technology USA, ENCOS, and NexCOBOT, who shared their perspectives on the EAI robotics industry and FF’s "Built in USA" initiative. FF announces further execution plans for phase two of the "Built in USA" acceleration program, accelerating the rollout of the Next Futurist and Next Aegis series, initiating the conditional approval application
- Apollo Funds Announce Completion of Acquisition of Nippon Sheet Glass, Marking New Chapter of Growth
TOKYO and NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE:APO) today announced the successful completion of Apollo managed funds’ ("Apollo Funds") acquisition of Nippon Sheet Glass Co., Ltd., a leading global company in architectural, automotive, and solar glass, and the launch of its new management structure, marking the new beginning of its next phase of growth. This transaction by Apollo Funds and key financial institutions will support the strengthening of the company’s financial foundation to accelerate investments in its people and technology. Drawing on Apollo’s prior investment experience in glass, automotive, and manufacturing sectors, the company will further capitaliz
- Namib Minerals Secures US$6.5 Million Term Loan Facility to Partially Fund Resource Definition and Bankability
New York, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Namib Minerals ("Namib" or "the Company") (NASDAQ:NAMM), today announced that Bulawayo Mining Company (Private) Limited, a wholly owned subsidiary of the Company, has secured a non-dilutive new term loan facility for US$ 6.5 million (the "New Term Loan Facility") with African Banking Corporation of Zimbabwe Limited ("BancABC"). The New Term Loan Facility is in addition to the Company’s existing term loan and overdraft facilities with BancABC, with all such facilities consolidated into a single facility (the "Facility"). The Facility strengthens the Company's liquidity and working capital position with the funds from the New Term Loan Facility e
- KKR Sells CTT's Japan and Korea Businesses to Institutional Investors
Global investment firm KKR today announced that funds managed by KKR have entered into separate agreements with institutional investors to sell Central Tank Terminal Co., Ltd. ("CTT") in Japan and Central Terminal Korea Co., Ltd. ("CTK") in Korea. CTT operates 12 tank-storage terminals across Japan’s key industrial regions, with more than 450 tanks and 420,000 kiloliters of capacity. In Korea, CTK operates a tank-terminal complex in Ulsan and grain-silo facilities in Ulsan and Pyeongtaek. Together, the businesses provide critical storage, handling and related services to chemical, energy, logistics and agricultural customers. KKR acquired CTT in 2021 and expanded the platform into Korea
- Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder
Study met its primary endpoint: timing of sleep onset shifted 37.1 minutes earlier versus placebo (p=0.022)60% of HETLIOZ® treated participants shifted sleep at least 30 minutes earlier, compared to 15% of the placebo armWASHINGTON, Sept. 29, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) today announced positive topline results from its pivotal Phase III study of HETLIOZ® (tasimelteon) 20 mg in adults with Delayed Sleep-Wake Phase Disorder (DSWPD). Vanda intends to discuss these data with the U.S. Food and Drug Administration (FDA) and to submit a supplemental New Drug Application (sNDA) seeking approval of HETLIOZ® for DSWPD. If approved, HETLIOZ® would be the first FDA-appr
- ICM Bluebird Canadian Self Storage LP Announces Agreement for Strategic Joint Venture with SmartStop Self Storage REIT, Inc.
CALGARY, AB, Sept. 29, 2026 /CNW/ -- ICM Bluebird Canadian Self Storage LP (the "Fund"), one of Canada's leading institutional self-storage investment platforms, announced it has entered into an agreement for a strategic joint venture with SmartStop Self Storage REIT, Inc. ("SmartStop") (NYSE:SMA), a premier owner and operator of self-storage facilities in the United States and Canada. Under the agreement, SmartStop has agreed to commit up to $300 million in total capital, which is expected to mark a transformative new chapter for the Fund and its investors.Under the proposed structure, SmartStop will acquire an interest in the Fund's general partner alongside its multi-year capital commitme
- Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
NEW YORK, Sept. 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on September 30, 2026 and cumulative distributions paid fiscal year-to-date.In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term
- Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
NEW YORK, Sept. 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of the distribution to be paid on September 30, 2026 and cumulative distributions paid fiscal year-to-date.In December 2012, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term
- Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
NEW YORK, Sept. 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI) (the "Fund") with information regarding the sources of the distribution to be paid on September 30, 2026 and cumulative distributions paid fiscal year-to-date.In December 2011, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term cap
- Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
NEW YORK, Sept. 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE:RNP) (the "Fund") with information regarding the sources of the distribution to be paid on September 30, 2026 and cumulative distributions paid fiscal year-to-date.In December 2017, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize lon
- Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
NEW YORK, Sept. 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on September 30, 2026 and cumulative distributions paid fiscal year-to-date.In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term capital ga
- HII Wins U.S. Navy Contract for 10 ROMULUS USVs, Accelerating Deployment of Proven Autonomous Capability
MCLEAN, Va., Sept. 29, 2026 (GLOBE NEWSWIRE) -- HII (NYSE:HII), America’s largest military shipbuilder and the global leader in autonomous seapower, was awarded a contract by the U.S. Navy to build 10 ROMULUS unmanned surface vessels (USVs) for the Medium Unmanned Surface Vessel (MUSV) program. The award marks a major advancement in the U.S. Navy’s transition from experimentation to fleet-scale deployment of trusted, operational autonomy across the maritime domain. "HII has made deliberate, early investments in the development of autonomous systems, advancing capabilities essential to the Navy’s hedge strategy," said Chris Kastner, HII president and CEO. "We remain firmly committed to sup
- DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years
Châtillon, France, September 29, 2026 DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years The BLA is supported by the results from the successful Phase 3 VITESSE trial – the largest immunotherapy clinical trial to date for this population. DBV has requested Priority Review of the BLA. DBV Technologies (TRQX:DBVp), a late-stage biopharmaceutical company, today announced that the Company has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the VIASKIN® Peanut Patch in children with peanut allergy aged 4 through 7 years. DBV has requested Priority Revi
- Independent Bank Corporation Announces Date for Its Third Quarter 2026 Earnings Release
GRAND RAPIDS, Mich., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Independent Bank Corporation (NASDAQ:IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2026 third quarter results on Tuesday, October 27, 2026, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the "News" section of the "Investor Relations" area of the Company’s website. Brad Kessel, President and CEO, Gavin Mohr, CFO and Joel Rahn, EVP Commercial Banking will review the quarterly results in a conference call for investors and analysts beginning at 11:00 am ET on Tuesday, October 27, 2026. To access via phone,
- Aberdeen Investments U.S. Closed-End Funds Announce Results of Annual Meeting of Shareholders
PHILADELPHIA, Sept. 29, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds announced they each held their Annual Meeting of Shareholders (the "Meetings") on September 29, 2026. At the Meetings, shareholders of the respective Funds voted on the proposals set forth below:Aberdeen Government Markets Income Fund ("MGF")As of the record date, August 3, 2026, MGF had 32,590,193 outstanding shares of common stock. 85.49% of outstanding common stock were voted representing a quorum.To elect one Trustee to the Fund:Votes ForVotes Against/WithheldVotes AbstainedGordon Baird 25,105,4162,756,3470Aberdeen Intermediate Income Fund ("MIN")As of the record date, August 3, 2026,
- ServisFirst Bancshares, Inc. to Announce Third Quarter 2026 Financial Results October 19th
BIRMINGHAM, Ala., Sept. 29, 2026 (GLOBE NEWSWIRE) -- ServisFirst Bancshares, Inc. (NYSE:SFBS) is scheduled to announce earnings and operating results for the quarter ended September 30, 2026 on October 19, 2026 at 4 p.m. ET. The news release will be available at www.servisfirstbancshares.com. ServisFirst Bancshares, Inc. will host a live audio webcast to discuss earnings and results on Monday, October 19, 2026 beginning at 5:15 p.m. ET. The audio webcast can be accessed at www.servisfirstbancshares.com. A replay of the call will be available until October 31, 2026. About ServisFirst Bancshares, Inc. ServisFirst Bancshares, Inc. is a bank holding company based in Birmingham, Alabama. Thr
- CORRECTING and REPLACING Northern Trust Announces Chief Financial Officer Transition
Please replace the release with the following corrected version due to multiple revisions. The updated release reads: NORTHERN TRUST ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION Northern Trust Corporation announced today that Dave Fox, Chief Financial Officer, has announced his retirement after a long and distinguished career in financial services. Fox intends to remain in his role through the end of the first quarter of 2027 to support a thoughtful and orderly transition. Northern Trust plans to conduct a comprehensive internal and external search for its next Chief Financial Officer. During this time, it is expected that Fox will continue to lead Finance and work closely with Mich
- Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology
Press release – No. 18 / 2026 Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology Treatment with petrelintide was associated with clinically meaningful, double-digit weight loss, with a gastrointestinal tolerability profile comparable to placeboTreatment was associated with significant improvements in cardiometabolic disease risk factors, including reductions in pulse rate, high-sensitivity C-reactive protein and waist circumferenceAdditional results from the ZUPREME-1 study will be presented in an oral presentation at EASD 2026 on September 30 at 3:30pm CESTA
- Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over 80 weeks, with more than half no longer meeting the BMI criteria for obesityParticipants with a baseline BMI of 35 or higher who took retatrutide 12 mg lost up to an average of 60.8 lbs (23.4%) of their body weightRetatrutide reduced A1C by up to an average of 1.6%, with up to 40.0% reaching an A1C of <5.7%INDIANAPOLIS, Sept. 29, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety of retatrutide, an inv